Brokerages Set Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Target Price at $21.80

Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) have been assigned an average recommendation of “Moderate Buy” from the ten brokerages that are covering the firm, MarketBeat Ratings reports. Five investment analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $21.80.

A number of equities research analysts recently weighed in on SBRA shares. Citizens Jmp boosted their price target on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a research report on Wednesday, February 18th. Cantor Fitzgerald raised their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a report on Tuesday, February 17th. Truist Financial lifted their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “hold” rating in a research report on Tuesday, January 20th. Citigroup boosted their target price on Sabra Healthcare REIT from $21.00 to $24.00 and gave the company a “buy” rating in a report on Wednesday, February 18th. Finally, Wall Street Zen cut Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research report on Friday, January 23rd.

Sabra Healthcare REIT Price Performance

Shares of NASDAQ SBRA opened at $20.65 on Monday. The stock’s 50-day simple moving average is $19.58 and its 200-day simple moving average is $18.99. The firm has a market capitalization of $5.21 billion, a PE ratio of 32.27, a price-to-earnings-growth ratio of 1.67 and a beta of 0.64. Sabra Healthcare REIT has a fifty-two week low of $15.75 and a fifty-two week high of $21.07. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.29 and a current ratio of 4.29.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.26). Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. The business had revenue of $201.35 million during the quarter, compared to analyst estimates of $201.97 million. During the same period last year, the company earned $0.36 earnings per share. The business’s revenue for the quarter was up 16.2% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, equities research analysts forecast that Sabra Healthcare REIT will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 27th. Shareholders of record on Friday, February 13th were paid a $0.30 dividend. The ex-dividend date was Friday, February 13th. This represents a $1.20 dividend on an annualized basis and a yield of 5.8%. Sabra Healthcare REIT’s payout ratio is currently 187.50%.

Hedge Funds Weigh In On Sabra Healthcare REIT

Hedge funds have recently modified their holdings of the business. Cornerstone Wealth Management LLC lifted its stake in shares of Sabra Healthcare REIT by 256.6% in the third quarter. Cornerstone Wealth Management LLC now owns 39,781 shares of the real estate investment trust’s stock valued at $742,000 after purchasing an additional 28,625 shares during the period. AlphaQuest LLC grew its position in Sabra Healthcare REIT by 309.2% during the third quarter. AlphaQuest LLC now owns 144,839 shares of the real estate investment trust’s stock worth $2,700,000 after buying an additional 109,444 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al grew its position in Sabra Healthcare REIT by 51.2% during the third quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 577,800 shares of the real estate investment trust’s stock worth $10,770,000 after buying an additional 195,600 shares during the period. Franklin Resources Inc. increased its holdings in Sabra Healthcare REIT by 27.4% in the second quarter. Franklin Resources Inc. now owns 503,499 shares of the real estate investment trust’s stock valued at $9,285,000 after buying an additional 108,268 shares in the last quarter. Finally, Allianz Asset Management GmbH increased its holdings in Sabra Healthcare REIT by 9.9% in the third quarter. Allianz Asset Management GmbH now owns 902,998 shares of the real estate investment trust’s stock valued at $16,832,000 after buying an additional 81,293 shares in the last quarter. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.